Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination
Abstract Thrombosis with thrombocytopenia syndrome (TTS) is a rare but potentially severe adverse event following immunization with adenovirus vector-based COVID-19 vaccines such as Ad26.COV2.S (Janssen) and ChAdOx1 (AstraZeneca). However, no case of TTS has been reported in over 1.5 million individ...
Main Authors: | Malika Aid, Kathryn E. Stephenson, Ai-ris Y. Collier, Joseph P. Nkolola, James V. Michael, Steven E. McKenzie, Dan H. Barouch |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-42559-x |
Similar Items
-
Factors Associated with Thrombosis in
Primary Immune Thrombocytopenia
by: YANG Shuo, WANG Yong, CHEN Shuxia, ZHAO Mingfeng
Published: (2022-02-01) -
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
by: Michael Makris, et al.
Published: (2021-07-01) -
The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis
by: Nebojsa Antonijevic, et al.
Published: (2024-03-01) -
Very Late Stent Thrombosis Complicating Immune Thrombocytopenia
by: Hisanobu Shimazu, MD, et al.
Published: (2023-10-01) -
Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis
by: Tia C.L. Kohs, et al.
Published: (2022-05-01)